 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
1 July 1994 | Volume 121 Issue 1 | Pages 62-70
The National Institutes of Health Consensus Development Conference on Morbidity and Mortality of Dialysis brought together experts in general medicine, nephrology, pediatrics, biostatistics, and nutrition, as well as a representative of the public, to address the following questions: 1) How does early medical intervention in predialysis patients influence morbidity/mortality? 2) What is the relationship between delivered dialysis dose and morbidity/mortality? 3) Can comorbid conditions be altered by nondialytic interventions to improve morbidity/mortality in dialysis patients? 4) How can dialysis-related complications be reduced? and 5) What are the future directions for research in dialysis? After one and a half days of presentations by experts and discussion by the audience, a consensus panel weighed the evidence and prepared their consensus statement.
Among their findings, the consensus panel concluded the following: 1) During the period before dialysis therapy begins, patients, including children, should be referred to a renal team to reduce the morbidity and mortality incurred during this period and during subsequent dialysis therapy; 2) the social and psychological welfare and the quality of life of the patient receiving dialysis are favorably influenced by the early and continued involvement of a multidisciplinary renal team; 3) to avoid a catastrophic onset of dialysis, attempts should be made to institute intervention before dialysis therapy begins and to appropriately initiate dialysis access; 4) quantitative methods now available to objectively evaluate the relation between the delivered dose of dialysis and patient morbidity and mortality suggest that the dose of hemodialysis and peritoneal dialysis has been suboptimal for many patients in the United States; 5) factors contributing to the underdialysis of some patients include problems with vascular and peritoneal access, nonadherence to dialysis prescription, and underprescription of the dialysis dose; 6) cardiovascular mortality accounts for approximately 50% of deaths in patients receiving dialysis, and relative risk factors such as hypertension, smoking, and chronic anemia should be treated as soon as possible after the diagnosis of chronic renal failure; 7) early detection and treatment of malnutrition contribute to the improved survival of patients receiving dialysis; and 8) until randomized controlled trials have been completed, a delivered hemodialysis dose at least equal to a measured fractional urea clearance Kdr t/V value of 1.2 (single pool) and a delivered peritoneal dialysis dose at least equal to a measured Kpr t/V value of 1.7 (weekly) are recommended.
Author and Article Information
For panel and planning committee members, see Appendix.
CONSENSUS
Morbidity and Mortality of Renal Dialysis: An NIH Consensus Conference Statement
This article has been cited by other articles:
|
|
 |
|
  D. C. Mendelssohn Coping with the CKD epidemic: the promise of multidisciplinary team-based care Nephrol. Dial. Transplant., January 1, 2005; 20(1): 10 - 12. [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Winkelmayer, R. Kewalramani, M. Rutstein, S. Gabardi, T. Vonvisger, and A. Chandraker Pharmacoepidemiology of Anemia in Kidney Transplant Recipients J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1347 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Hocher, R. Ziebig, C. Altermann, R. Krause, G. Asmus, C.-M. Richter, T. Slowinski, P. Sinha, and H.-H. Neumayer Different Impact of Biomarkers as Mortality Predictors among Diabetic and Nondiabetic Patients Undergoing Hemodialysis J. Am. Soc. Nephrol., September 1, 2003; 14(9): 2329 - 2337. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Weisbord, S. S. Carmody, F. J. Bruns, A. J. Rotondi, L. M. Cohen, M. L. Zeidel, and R. M. Arnold Symptom burden, quality of life, advance care planning and the potential value of palliative care in severely ill haemodialysis patients Nephrol. Dial. Transplant., July 1, 2003; 18(7): 1345 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. G. Levinsky Specialist Evaluation in Chronic Kidney Disease: Too Little, Too Late Ann Intern Med, September 17, 2002; 137(6): 542 - 543. [Full Text] [PDF]
|
|
|
|
|
|
G. B. Piccoli, G. Grassi, E. Mezza, M. Gai, C. Iacuzzo, F. Bechis, L. Biancone, A. Jeantet, F. Dani, P. C. Perin, et al. Early referral of Type 2 diabetic patients: are we ready for the assault? Nephrol. Dial. Transplant., July 1, 2002; 17(7): 1241 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Rais-Keely Nutrition Interventions in Early Diabetic Renal Disease The Diabetes Educator, January 1, 2002; 28(1): 62 - 70. [PDF]
|
|
|
|
 |
|
 C. M. V. Zielinski, S. K. Mittal, P. Anderson, J. Cummings, S. Fenton, J. Reiland-Smith, J. T. Frock, and R. W. Dunlay Delayed Superficialization of Brachiobasilic Fistula: Technique and Initial Experience Arch Surg, August 1, 2001; 136(8): 929 - 932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. NISSENSON, A. J. COLLINS, J. HURLEY, H. PETERSEN, B. J. G. PEREIRA, and E. P. STEINBERG Opportunities for Improving the Care of Patients with Chronic Renal Insufficiency: Current Practice Patterns J. Am. Soc. Nephrol., August 1, 2001; 12(8): 1713 - 1720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. KAUSZ, S. S. KHAN, R. ABICHANDANI, W. H. KAZMI, G. T. OBRADOR, R. RUTHAZER, and B. J. G. PEREIRA Management of Patients with Chronic Renal Insufficiency in the Northeastern United States J. Am. Soc. Nephrol., July 1, 2001; 12(7): 1501 - 1507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Weinstein Lessons from an Epidemic, Again N. Engl. J. Med., May 17, 2001; 344(20): 1544 - 1545. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Y. Liu, N. J. O. Birkmeyer, J. H. Sanders, J. R. Morton, H. F. Henriques, S. J. Lahey, R. W. Dow, C. Maloney, A. W. DiScipio, R. Clough, et al. Risks of Morbidity and Mortality in Dialysis Patients Undergoing Coronary Artery Bypass Surgery Circulation, December 12, 2000; 102(24): 2973 - 2977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Dierkes, U. Domrose, S. Westphal, A. Ambrosch, H.-P. Bosselmann, K. H. Neumann, and C. Luley Cardiac Troponin T Predicts Mortality in Patients With End-Stage Renal Disease Circulation, October 17, 2000; 102(16): 1964 - 1969. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Virga, G. Amici, S. Mastrosimone, G. Biasio, L. Stanic, G. D. Rin, and A. Bonadonna Day-to-day variability of adequacy indexes in peritoneal dialysis Nephrol. Dial. Transplant., December 1, 1999; 14(12): 2932 - 2936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Jungers Screening for renal insufficiency: is it worth while? is it feasible? Nephrol. Dial. Transplant., September 1, 1999; 14(9): 2082 - 2084. [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Mendelssohn, B. J. Barrett, L. M. Brownscombe, J. Ethier, D. E. Greenberg, S. D. Kanani, A. Levin, and E. B. Toffelmire Elevated levels of serum creatinine: recommendations for management and referral Can. Med. Assoc. J., August 1, 1999; 161(4): 413 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. TZAMALOUKAS, G. H. MURATA, B. PIRAINO, D. MALHOTRA, J. BERNARDINI, P. RAO, and D. G. OREOPOULOS The Relation Between Body Size and Normalized Small Solute Clearances in Continuous Ambulatory Peritoneal Dialysis J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1575 - 1581. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Ahmad, T Farrant, F. J Caskey, W. Metcalfe, A. M MacLeod, I. H Khan, S. M Chandna, R. N Greenwood, and K. Farrington Is there a rationale for rationing chronic dialysis? BMJ, June 12, 1999; 318(7198): 1619 - 1619. [Full Text]
|
|
|
|
|
|
P. ARORA, G. T. OBRADOR, R. RUTHAZER, A. T. KAUSZ, K. B. MEYER, C. S. JENULESON, and B. J. G. PEREIRA Prevalence, Predictors, and Consequences of Late Nephrology Referral at a Tertiary Care Center J. Am. Soc. Nephrol., June 1, 1999; 10(6): 1281 - 1286. [Abstract] [Full Text]
|
|
|
|
|
|
S. M Chandna, J. Schulz, C. Lawrence, R. N Greenwood, and K. Farrington Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity BMJ, January 23, 1999; 318(7178): 217 - 223. [Abstract] [Full Text]
|
|
|
|
|
|
O. Ifudu Care of Patients Undergoing Hemodialysis N. Engl. J. Med., October 8, 1998; 339(15): 1054 - 1062. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Baum, S. Braun, W. Gerhardt, G. Gilson, G. Hafner, M. Muller-Bardorff, W. Stein, G. Klein, C. Ebert, K. Hallermayer, et al. Multicenter evaluation of a second-generation assay for cardiac troponin T Clin. Chem., October 1, 1997; 43(10): 1877 - 1884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Sonnenberg Immunoglobulin Therapy for IgA Nephropathy: When Is Cost Saving Enough? Med Decis Making, October 1, 1996; 16(4): 420 - 421. [PDF]
|
|
|
|
|
|
O. Ifudu, J. Feldman, and E. A. Friedman The Intensity of Hemodialysis and the Response to Erythropoietin in Patients with End-Stage Renal Disease N. Engl. J. Med., February 15, 1996; 334(7): 420 - 425. [Abstract] [Full Text] [PDF]
|
|
Article
